Top Markets
Coin of the day
Instem plc Instem plc

Instem plc

INS
주식 순위 #19527
Established in 1969 and based in Stone, United Kingdom, Instem plc provides... Established in 1969 and based in Stone, United Kingdom, Instem plc provides information technology applications to the global life sciences and healthcare sectors. The company's core mission is to equip organizations with robust solutions for data capture, management, and analysis, thereby facilitating informed, data-driven decision-making processes. Instem's extensive suite of offerings addresses diverse needs across research and development. For early-phase clinical trials, it offers ALPHADAS, an eSource system. Discovery research is supported by tools like BioRails for data management and Morphit for data visualization. The portfolio also includes computational toxicology products and services, alongside Provantis, a Windows-based system for non-clinical evaluation studies. Specialized solutions comprise Comet Assay IV, a live video imaging system for reproducible comet slide scoring, and Cyto Study Manager for cytology data acquisition and reporting. Furthermore, NOTOCORD-hem software platforms are available for acquiring, displaying, and analyzing physiological signals. A significant area of focus is regulatory information management. Instem provides Samarind RMS for managing medical product information and a comprehensive set of tools for the Standard for Exchange of Nonclinical Data (SEND). This includes the submit platform for creating and managing SEND datasets, SENDView for reviewing them, SEND Explorer for web-based access with optional data warehousing, and SENDTrial, a subscription-based web solution. Other offerings include Logbook, an information repository, and the Sorcerer Colony Counter for automatic plate counting. Beyond its software products, Instem delivers a broad range of services such as sales support, training, validation, consultancy, and cloud services, in addition to safety assessment and regulatory information management software. The company also develops, manufactures, and supplies both software and hardware specifically for in vitro study data collection and management, enabling intelligence extraction from R&D related healthcare data.
주가
$10.38
마지막 동기화: 2023-11-20
시가총액
$158.81M
변동 (1일)
-7.99%
변동 (1년)
0.00%
국가
GB
거래 Instem plc (INS)

카테고리

Instem plc (INS)의 영업이익률
2026 기준 영업이익률 TTM: 0.00%
Instem plc의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 0.00%입니다. 2026년 말 기준 영업이익률은 0.00%였습니다.
Instem plc의 영업이익률 기록 (2026 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
12.70% -
US
74.17% -
AU
-19.76% -
US
3.33% -
US
0.00% -
US
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.